ArticleCancer medicine2025
Epidemiological Profile of Non-Hodgkin's Lymphomas Seen at Kinshasa University Clinics From 2012 to 2022.
Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionNon-Hodgkin lymphoma (NHL) is a heterogeneous group of cancers whose global incidence has been increasing in recent years. In the DRC, the absence of a national cancer registry is a serious handicap to the epidemiological evaluation of NHL. There is still a lack of knowledge about this pathology among the population and health professionals. An observational survey of the country's hospitals is enough to note the absence of protocols for the management of NHL. The objective of this study is to determine the epidemiological aspects of non-Hodgkin lymphoma in the DRC. MATERIALS AND
methodsA descriptive cross-sectional study, conducted at the University Clinics of Kinshasa, from 2012 to 2022. The chi-square correlation test is used to compare proportions with the 95% confidence interval (α = 0.05).
resultsOut of a total of 2070 cancer cases, 51 NHL cases were recorded, or 2.5%. 98% of the recorded cases were B-cell lymphomas compared to 2% T-cell lymphomas. 80% of cases were aggressive and 20% were indolent. 55% of cases were male versus 45% female, with a sex ratio of 1.2. The age of the patients ranged from 3 to 80 years, with a mean age of 42 years and a median of 45 years. The histological type DLBCL was predominant in 63% of cases. 59% of cases involved lymph nodes.
conclusionNon-Hodgkin lymphoma (NHL) is a heterogeneous group of cancers whose global incidence has been increasing in recent years, with the outbreak of environmental and infectious factors. Knowledge of epidemiological aspects contributes to the improvement of the fight against NHL in the DRC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.